8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 5, 2020

Baxter International Inc.

(Exact name of registrant as specified in its charter)

Delaware

1-4448

36-0781620

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(I.R.S. Employer

Identification No.)


One Baxter Parkway, Deerfield, Illinois		60015
(Address of principal executive offices)		(Zip Code)

(224) 948-2000

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d 2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $1.00 par value	BAX (NYSE)	New York Stock Exchange
		Chicago Stock Exchange
1.3% Global Notes due 2025	BAX 25	New York Stock Exchange
1.3% Global Notes due 2029	BAX 29	New York Stock Exchange
0.4% Global Notes due 2024	BAX 24	New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)

☐ Emerging Growth Company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(e) of the Exchange Act ☐

Item 5.07

Submission of Matters to a Vote of Security Holders

On May 5, 2020, the Company held its annual meeting of stockholders. Of the 507,206,095 shares outstanding and entitled to vote, 448,832,882 shares were represented at the meeting, constituting a quorum of approximately 88%. The following is a summary of the matters voted on at the meeting.

(a)	The twelve nominees for director were elected as follows:


Nominee	For		Against		Abstain		Broker Non-Votes
José (Joe) Almeida		382,026,278		24,167,622		2,018,926		40,620,056
Thomas F. Chen		406,126,816		1,743,763		342,247		40,620,056
John D. Forsyth		384,193,917		23,666,406		352,503		40,620,056
James R. Gavin III		377,261,128		21,931,325		9,020,373		40,620,056
Peter S. Hellman		388,573,884		19,286,262		352,680		40,620,056
Michael F. Mahoney		404,893,062		2,950,702		369,062		40,620,056
Patricia B. Morrison		403,687,982		4,214,330		310,514		40,620,056
Stephen N. Oesterle		406,169,367		1,692,842		350,617		40,620,056
Cathy R. Smith		402,601,923		5,306,10 2		304,801		40,620,056
Thomas T. Stallkamp		381,744,114		26,131,439		337,273		40,620,056
Albert P.L. Stroucken		365,190,197		42,666,324		356,305		40,620,056
Amy A. Wendell		406,338,786		1,561,903		312,137		40,620,056

(b)	By the following vote, stockholders approved, on an advisory basis, the 2019 compensation paid to the Company’s named executive officers:


For	Against	Abstain	Broker Non-Votes
385,973,624	21,429,316	809,886	40,620,056

(c)	The appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2020 was ratified by the following vote:


For	Against	Abstain
419,978,522	28,269,180	585,180

(d)	By the following vote, stockholders approved the stockholder proposal relating to an independent board chairman:


For	Against	Abstain	Broker Non-Votes
223,977,699	183,242,630	992,497	40,620,056

(e)	By the following vote, stockholders did not approve the stockholder proposal relating to the right to act by written consent:


For	Against	Abstain	Broker Non-Votes
156,711,231	249,777,001	1,724,594	40,620,056

Document and Entity Information	May 05, 2020
Document And Entity Information [Line Items]
Entity Registrant Name	BAXTER INTERNATIONAL INC
Amendment Flag	false
Entity Central Index Key	0000010456
Document Type	8-K
Document Period End Date	May 05, 2020
Entity Incorporation State Country Code	DE
Entity File Number	1-4448
Entity Tax Identification Number	36-0781620
Entity Address, Address Line One	One Baxter Parkway
Entity Address, City or Town	Deerfield
Entity Address, State or Province	IL
Entity Address, Postal Zip Code	60015
City Area Code	(224)
Local Phone Number	948-2000
Written Communications	false
Soliciting Material	false
Pre Commencement Tender Offer	false
Pre Commencement Issuer Tender Offer	false
Entity Emerging Growth Company	false
Common Stock 100 Per Value [Member]
Document And Entity Information [Line Items]
Security 12b Title	Common Stock, $1.00 par value
Trading Symbol	BAX (NYSE)
Security Exchange Name	NYSE
M 0 [Member]
Document And Entity Information [Line Items]
Security Exchange Name	CHX
Global Notes 13 Due 2025 [Member]
Document And Entity Information [Line Items]
Security 12b Title	1.3% Global Notes due 2025
Trading Symbol	BAX 25
Security Exchange Name	NYSE
Global Notes 13 Due 2029 [Member]
Document And Entity Information [Line Items]
Security 12b Title	1.3% Global Notes due 2029
Trading Symbol	BAX 29
Security Exchange Name	NYSE
Global Notes 04 Due 2024 [Member]
Document And Entity Information [Line Items]
Security 12b Title	0.4% Global Notes due 2024
Trading Symbol	BAX 24
Security Exchange Name	NYSE

Document and Entity Information

May 05, 2020

Document And Entity Information [Line Items]

Entity Registrant Name

BAXTER INTERNATIONAL INC

Amendment Flag

false

Entity Central Index Key

0000010456

Document Type

8-K

Document Period End Date